placeholder image
M. P. Mehta All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. 
    Neuro-Oncology. 2023
  • Beyond an updated graded prognostic assessment (Breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. 
    International Journal of Radiation Oncology, Biology, Physics. 2020
  • Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival. 
    Neuro-Oncology. 2020
  • Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. 
    Journal of Clinical Oncology. 2020
  • Estimating survival in patients with gastrointestinal cancers and brain metastases: an update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
    2019
  • Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?. 
    Translational Research: The Journal of Laboratory and Clinical Medicine. 2019
  • Brain metastases in lung cancer with targetable mutations-reply. 
    JAMA oncology. 2018
  • Effect of targeted therapies on prognostic factors, patterns of care, and survival in patients with renal cell carcinoma and brain metastases. 
    International Journal of Radiation Oncology, Biology, Physics. 2018
  • Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. 
    Neuro-Oncology. 2018
  • Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study. 
    Journal of Neuro-Oncology. 2018
  • Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (lung-molGPA). 
    JAMA oncology. 2017
  • The effect of gene alterations and tyrosine kinase inhibition on survival and cause of death in patients with adenocarcinoma of the lung and brain metastases. 
    International Journal of Radiation Oncology, Biology, Physics. 2016
    • Editorial Article
  • Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation [editorial]. 
    Lancet Oncology.  19. 2018
    • Contact
    full name
  • M. P. Mehta
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration